Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05057247
Title Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Glenn J. Hanna
Indications

paranasal sinus cancer

nasal cavity squamous cell carcinoma

hypopharynx cancer

oral squamous cell carcinoma

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma

oropharynx cancer

Therapies

Docetaxel + Duvelisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.